您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > BRD9876
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
BRD9876
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
BRD9876图片
CAS NO:32703-82-5
包装与价格:
包装价格(元)
1g电议
5g电议

产品介绍
BRD9876 是一种"严格"抑制剂,可将 kinesin-5 (Eg5) 锁定在具有增强的微管 (MTs) 结合的状态,从而导致 MTs 的捆绑和稳定。 BRD9876 与酪氨酸 104 残基相互作用,该残基是 α4-α6 变构结合口袋的一部分。 BRD9876 特异性靶向微管结合的 Eg5,并选择性地抑制 CD34 细胞上的骨髓瘤。 BRD9876 具有用于多发性骨髓瘤 (MM) 研究的潜力。
Cas No.32703-82-5
别名6-叔丁基-2,3-二氰基萘
Canonical SMILESN#CC1=CC2=CC=C(C(C)(C)C)C=C2C=C1C#N
分子式C16H14N2
分子量234.3
溶解度Chloroform: 10 mg/ml,DMF: 1 mg/ml,DMF:PBS (pH 7.2) (1:2): 0.33 mg/ml
储存条件-20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

BRD9876 is an inhibitor of the kinesin spindle protein Eg5.1It arrests Eg5-mediated microtubule gliding, as well as inhibits Eg5 ATPase activity in the presence of microtubules, in cell-free assays. BRD9876 is cytotoxic to MM.1S stroma-independent multiple myeloma cells (IC50= 2.2 µM). It induces cell cycle arrest at the G2/M phase in MM.1S cells when used at a concentration of 10 µM.

1.Chattopadhyay, S., Stewart, A.L., Mukherjee, S., et al.Niche-based screening in multiple myeloma identifies a kinesin-5 inhibitor with improved selectivity over hematopoietic progenitorsCell Rep.10(5)755-770(2015)